Table 1 Demographic and clinical features of control subjects*
From: Corticosteroid therapy in a patient with cerebral amyloid angiopathy-related inflammation
Feature | Alzheimer’s disease | Multiple sclerosis |
|---|---|---|
No. patients | 14 | 7 |
Gender, female / male | 7 / 7 | 5 / 2 |
Age at evaluation (y) | 73 ± 9 | 42 ± 9 |
Age at onset (y) | 72 ± 9 | 30 ± 10 |
Disease duration (y) | 1.9 ± 0.7 | 12 ± 8 |
Immunomodulatory therapy† | None | Prednisolone, 5 mg/day (1 patient); interferon β1b, 8 MIU/every other day (2 patients); mizoribine, 50 mg/day (1 patient) |